Literature DB >> 8686777

The epidemiology of acute adenolymphangitis due to lymphatic filariasis in northern Ghana.

J O Gyapong1, M Gyapong, S Adjei.   

Abstract

A study to investigate the socioeconomic impact of lymphatic filariasis was conducted in a rural community in northern Ghana. The incidence, severity, and duration of acute adenolymphangitis (ADL), as identified by local terminologies and confirmed using World Health Organization diagnostic criteria, were investigated. Local terminologies were found to be highly specific and sensitive for diagnosing ADL (sensitivity = 0.978, specificity = 0.980). The incidence of ADL was 95.9 per 1,000 per annum among adults more than 10 years of age, being much higher in females than in males. Among those with elephantiasis and other chronic filarial symptoms, there was no clear relationship between the stage of chronic lymphedema and the incidence of ADL. The incidence of ADL was found to be closely related to the rainfall pattern. The design of the study, its findings, and the public health implications of the findings are discussed in this paper.

Entities:  

Mesh:

Year:  1996        PMID: 8686777     DOI: 10.4269/ajtmh.1996.54.591

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  12 in total

1.  A refined and updated health impact assessment of the Global Programme to Eliminate Lymphatic Filariasis (2000-2020).

Authors:  Hugo C Turner; Eric A Ottesen; Mark H Bradley
Journal:  Parasit Vectors       Date:  2022-05-28       Impact factor: 4.047

2.  The economic benefits resulting from the first 8 years of the Global Programme to Eliminate Lymphatic Filariasis (2000-2007).

Authors:  Brian K Chu; Pamela J Hooper; Mark H Bradley; Deborah A McFarland; Eric A Ottesen
Journal:  PLoS Negl Trop Dis       Date:  2010-06-01

3.  Feasibility and effectiveness of basic lymphedema management in Leogane, Haiti, an area endemic for bancroftian filariasis.

Authors:  David G Addiss; Jacky Louis-Charles; Jacquelin Roberts; Frederic Leconte; Joyanna M Wendt; Marie Denise Milord; Patrick J Lammie; Gerusa Dreyer
Journal:  PLoS Negl Trop Dis       Date:  2010-04-20

4.  Preadult stage parasites and multiple timed exposure to infective larvae are involved in development of limb edema in Brugia malayi-infected Indian leaf monkeys (Presbytis entellus).

Authors:  P K Murthy; M A Khan; H B Rajani; V M L Srivastava
Journal:  Clin Diagn Lab Immunol       Date:  2002-07

5.  Reduction in acute filariasis morbidity during a mass drug administration trial to eliminate lymphatic filariasis in Papua New Guinea.

Authors:  Daniel J Tisch; Neal D E Alexander; Benson Kiniboro; Henry Dagoro; Peter M Siba; Moses J Bockarie; Michael P Alpers; James W Kazura
Journal:  PLoS Negl Trop Dis       Date:  2011-07-12

6.  Impact of basic lymphedema management and antifilarial treatment on acute dermatolymphangioadenitis episodes and filarial antigenaemia.

Authors:  Ha El-Nahas; Am El-Shazly; M Abulhassan; Na Nabih; N Mousa
Journal:  J Glob Infect Dis       Date:  2011-07

7.  Epidemiology of episodic adenolymphangitis: a longitudinal prospective surveillance among a rural community endemic for bancroftian filariasis in coastal Orissa, India.

Authors:  Bontha V Babu; Abhay N Nayak; Kalpataru Dhal
Journal:  BMC Public Health       Date:  2005-05-19       Impact factor: 3.295

8.  Morbidity management in the Global Programme to Eliminate Lymphatic Filariasis: a review of the scientific literature.

Authors:  David G Addiss; Molly A Brady
Journal:  Filaria J       Date:  2007-02-15

9.  The health and economic benefits of the global programme to eliminate lymphatic filariasis (2000-2014).

Authors:  Hugo C Turner; Alison A Bettis; Brian K Chu; Deborah A McFarland; Pamela J Hooper; Eric A Ottesen; Mark H Bradley
Journal:  Infect Dis Poverty       Date:  2016-05-24       Impact factor: 4.520

10.  Economic Costs and Benefits of a Community-Based Lymphedema Management Program for Lymphatic Filariasis in Odisha State, India.

Authors:  Eileen Stillwaggon; Larry Sawers; Jonathan Rout; David Addiss; LeAnne Fox
Journal:  Am J Trop Med Hyg       Date:  2016-08-29       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.